
AVNS • NYSE
Unlock comprehensive alternative data signals to make better investment decisions

Track website visits, page views, unique visitors, and engagement metrics over time to gauge online interest and brand strength.

Monitor Twitter follower growth, engagement rates, and social media presence to understand brand reach and community sentiment.

Analyze TikTok follower trends and viral content performance to measure youth demographic appeal and cultural relevance.

Track Facebook page likes, comments, shares, and post engagement to assess community interaction and brand loyalty.

Monitor Instagram follower growth, engagement rates, and visual content performance across demographics.

Track YouTube channel growth, video views, and subscriber engagement to measure content marketing effectiveness.

Monitor LinkedIn company page followers and professional network growth to assess B2B brand strength and talent attraction.

Track open job positions and hiring trends as a leading indicator of company expansion, contraction, or strategic shifts.

Monitor employee headcount changes on LinkedIn to gauge organizational growth, restructuring, or cost-cutting measures.

Analyze sentiment scores from Reddit discussions to understand retail investor mood and potential price momentum.

Track daily news mentions across major publications to measure media attention, PR effectiveness, and market awareness.

View key financial metrics including Revenue, Net Income, EPS, Free Cash Flow, EBITDA, and Total Assets. Access 2-year quarterly charts for Revenue & Income and Free Cash Flow trends.

Analyze technical indicators including 50-day Simple Moving Average (SMA) with price overlay and Relative Strength Index (RSI) charts.
TrendEdge provides tools and data for research and educational purposes only and does not provide investment advice or personal recommendations.
You don't hold AVNS in your mock portfolio yet.
The negative EPS of -10.18 and a corresponding negative PE ratio of -1.21 indicate that Avanos Medical is currently unprofitable. This points to significant earnings pressure and likely one-time or ongoing charges that are weighing on the bottom line. Without evidence of a clear path back to sustained profitability, the financial profile leans negative for equity holders.
The stock trades at $12.35, modestly above its 200-day moving average of $11.94, and is up 5.2% over the last month, indicating a mild positive trend. However, the RSI at 45.27 is in neutral territory, showing neither overbought nor oversold conditions. Overall, the technical picture suggests a slight positive bias but without strong momentum in either direction.
Alternative data for Avanos Medical is mixed but leans negative. Web traffic of roughly 38,160 visitors per month is modest for a public medtech company, and job openings have declined 22.6% month over month, which can signal hiring caution or cost-cutting. Social media followings are growing slowly from relatively low bases, suggesting limited brand engagement momentum.
Combining negative earnings, modest technical strength, and soft alternative data, the overall picture for Avanos Medical currently skews bearish. While the stock trades slightly above its 200-day moving average and has risen in the last month, the lack of profitability and signals of cautious hiring and only tepid engagement limit conviction in a sustained upside move.
Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.
Key moves vs recent baseline (last day / last week)
Plain-English summary of the biggest drivers (informational)
Potential risk factors to review
Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.
Reassess your thesis if any of these occur: